Supplier control training module on horizon
This article was originally published in The Silver Sheet
FDA plans to develop Web-based training module that will highlight agency concerns about supplier control. The supplier control module will be developed for CDRH Learn by March, said Kim Trautman, FDA GMP/quality systems expert, who spoke during an Oct. 22 session of FDAnews' Fourth Annual FDA Inspections Summit in Bethesda, Md. CDRH Learn, found at www.fda.gov/Training/CDRHLearn/default.htm, includes a series of training modules that describe various aspects of device regulation. "It will be a free way for you to take information to your firm about FDA's supplier control requirements," Trautman says. The agency has been concerned about poor supplier control for several years ("The Silver Sheet" May 2007)
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.